PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2002Clinical and Vaccine Immunology94 citationsOpen Access

Bacteroides ovatusas the Predominant Commensal Intestinal Microbe Causing a Systemic Antibody Response in Inflammatory Bowel Disease

View Full Paper
SSShin SaitohSNSatoshi NodaYAYuji Aiba

Key Points

Key points are not available for this paper at this time.

Abstract

To clarify what bacterial species of commensal intestinal microbes are recognized as the antigens that induce a serum antibody response in patients with inflammatory bowel disease (IBD), 72 subjects consisting of 12 Crohn's disease patients, 30 ulcerative colitis patients, and 30 healthy volunteers were examined for their titers of serum antibody to these intestinal bacteria. In IBD patients, as a result, significant elevations of both the immunoglobulin G (IgG) and IgA titers to Bacteroides ovatus were found. Immunoblotting showed that a definite 19.5-kDa band of B. ovatus was bound to the serum antibody raised in IBD patients. It was thus concluded that B. ovatus causes serum antibody responses in IBD patients, and a 19.5-kDa molecule of this bacterium appears to be the responsible antigen, although the role of this event in pathogenesis remains unclear.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Saitoh et al. (2002) studied this question.

synapsesocial.com/papers/6a703187ac440176ef28d76fhttps://doi.org/10.1128/cdli.9.1.54-59.2002
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences1980 · 30,047 citations
  2. 2Reinstatement of Species Rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of Neotype Strains for Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers and Bacteroides thetaiotaomicron (Distaso) Castellani and Chalmers1976 · 123 citations
  3. 3Double blind, placebo controlled trial of metronidazole in Crohn's disease.1991 · 536 citations
  4. 4Purification and characterization of an enterotoxin from Bacteroides fragilis1992 · 96 citations
  5. 5Immunology of inflammatory bowel disease1996 · 64 citations